SAC Capital Lowers Stake in Momenta Phamaceuticals, Inc. (MNTA) to 4.6%
Tweet Send to a Friend
In an amended 13G filing on Momenta Phamaceuticals, Inc. (NASDAQ: MNTA), hedge ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
